Predictors and Moderators of Treatment Efficacy in Children and Adolescents with Autism Spectrum Disorder
- PMID: 33210939
- PMCID: PMC8986328
- DOI: 10.1080/15374416.2020.1833735
Predictors and Moderators of Treatment Efficacy in Children and Adolescents with Autism Spectrum Disorder
Abstract
Objective: The heterogeneous symptom presentation of autism spectrum disorder (ASD) requires clinicians to consider each child's unique constellation of symptoms and tailor intervention accordingly. Treatment moderators, though necessary to guide evidence-based treatment decisions, are significantly under-studied. This brief report aims to expand on previous literature by providing an overview of characteristics which may influence treatment outcome and specifying future directions to build on this preliminary evidence base.
Method: A subset of treatment modalities was identified from the National Clearinghouse on Autism Evidence and Practice Review Team's most recent report including discrete trial early intensive behaviorally based treatment, social skills training, and cognitive behavioral interventions. Within these treatment modalities, individual interventions with significant support were specifically discussed. Due to the lack of research on treatment moderators, a discussion of significant predictors of treatment outcome is also included.
Results: Preliminary evidence suggests that overall, treatment intensity, duration, and parent involvement are the most consistently identified predictors (and in some studies, moderators) of treatment outcome; sessions which occur more frequently, continue for longer periods of time, and include parent training or coaching may yield the best outcomes. Other characteristics, including age and IQ, have been widely debated, with differing results found across treatment modalities.
Conclusions: The sparsity of research demonstrates a clear need for continued research on moderators to guide clinical judgment. Future studies that recruit larger samples targeting specific ASD symptoms at specific ages may be more adequately powered to detect these moderating effects.
Conflict of interest statement
Disclosure Statement: Authors have no conflicts of interest to disclose. This brief report includes a condensed summary taken from a longer chapter published in the Treatment of Disorders in Childhood and Adolescence (4th Edition): Klinger, L.G., & Dudley, K.M. (2019). Autism spectrum disorder. In M.J. Prinstein, E.A. Youngstrom, E.J. Mash, and R.A. Barkley (Eds.). Treatment of disorders in childhood and adolescence (4th Edition, pp. 376–415). New York: Guilford.
References
-
- Christensen DL, Baio J, Braun KVN, Bilder D, Charles J, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Lee L, Pettygrove S, Robinson C, Schulz E, Wells C, Wingate MS, Zahorodny W, & Yeargin-Allsopp M (2016). Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C.: 2002), 65(3), 1–23. - PMC - PubMed
-
- Contaldo A, Colombi C, Pierotti C, Masoni P, & Muratori F (2020). Outcomes and moderators of Early Start Denver Model intervention in young children with autism spectrum disorder delivered in a mixed individual and group setting. Autism, 24(3), 718–729. - PubMed
-
- Gengoux G, Berquist KL, Salzman E, & Schapp S, Phillips JM, Frazier TW, Minjarez MB, & Hardan AY (2015). Pivotal response treatment parent training for autism: Findings from a 3-month follow-up evaluation. Journal of Autism and Developmental Disorders, 45(9), 2889–98. - PubMed
-
- Granpeesheh D, Tarbox J, & Dixon DR (2009). Applied behavior analytic interventions for children with autism: A description and review of treatment research. Annals of Clinical Psychiatry, 21(3), 162–173. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical